Breaking News
December 19, 2018 - RNA sequencing offers novel insights into the microbiome
December 19, 2018 - A promising, effective vaccine for common respiratory disease
December 19, 2018 - Protein may slow progression of emphysema, study finds
December 19, 2018 - Studying atrial fibrillation — and exploring new frontiers in precision health
December 19, 2018 - A New Way To Get College Students Through A Psychiatric Crisis — And Back To School
December 19, 2018 - Optum, UnitedHealthcare take action to help people affected by North Carolina winter storms
December 18, 2018 - Weight change in middle-aged, elderly Chinese Singaporeans related to increased risk of death
December 18, 2018 - Immune cells sacrifice themselves to protect us from invading bacteria
December 18, 2018 - Watching brain cells fire, with a twist of gravitational waves
December 18, 2018 - 2018 in Review
December 18, 2018 - Getting the Most Out of the CLARITY Technique
December 18, 2018 - NVF shoes provide a viable option for track and road racing
December 18, 2018 - CRISPR may restore effectiveness of chemotherapies used to treat lung cancer
December 18, 2018 - New app accurately measures and charts progression of skin wounds
December 18, 2018 - Persistent Discrimination ID’d Among Physician Mothers
December 18, 2018 - Cellphone technology developed to detect HIV
December 18, 2018 - A Stanford doctor hits the field with the 49ers — as their airway management physician
December 18, 2018 - The Rise of Anxiety Baking
December 18, 2018 - Just one night of sleep deprivation increases the urge to eat
December 18, 2018 - Study reveals mechanism behind failed remyelination in MS
December 18, 2018 - New genetic testing method increases the precision of biomarker analysis
December 18, 2018 - Simple technique to effectively treat underdiagnosed cause of debilitating chest pain
December 18, 2018 - Barbershop-based medical intervention can successfully lower blood pressure, new data shows
December 18, 2018 - Food labels have caused changes in consumers’ intake and industry’s use of key additives
December 18, 2018 - Sickest children could benefit from split liver transplants
December 18, 2018 - Scientists create patient-specific model to identify most effective treatment for appendix cancer
December 18, 2018 - ‘Little Foot’ endocast reveals a small brain combining ape-like and human-like features
December 18, 2018 - New therapy for childhood blindness shows ‘very promising’ results
December 18, 2018 - Researchers discover promising new compound against Buruli ulcer
December 18, 2018 - Study finds significant use of traditional, complementary and alternative medicines in Sub-Saharan Africa
December 18, 2018 - California Farm Implicated in Outbreak of E. coli Tied to Romaine Lettuce
December 18, 2018 - Mobile health has power to transform HIV/AIDS nursing
December 18, 2018 - Celiac Vaccine in Clinical Trials at Columbia
December 18, 2018 - Research into mental health first aid prompts practical guidance and resources for workplace
December 18, 2018 - Researcher conducts study to investigate peripheral blood markers of Alzheimer’s disease
December 18, 2018 - Researchers identify link between mucus in the small airways and pulmonary fibrosis
December 18, 2018 - EU Commission’s Health Policy Platform to host EKHA program on transplantation
December 18, 2018 - Survivors of childhood Hodgkin lymphoma have high risk of developing solid tumors
December 18, 2018 - Small changes to cafeteria design can get kids to eat healthier, new assessment tool finds
December 18, 2018 - From Machines to Cyclic Compounds
December 18, 2018 - New study reveals best assessment tools to establish delirium severity
December 18, 2018 - Rice University scientists develop synthetic protein switches to control electron flow
December 18, 2018 - Home-based pulmonary function monitoring for teens with Duchenne muscular dystrophy
December 18, 2018 - Researchers identify potential target for new breast cancer treatments
December 18, 2018 - National Biofilms Innovation Centre award grant to Neem Biotech for novel anti-biofilm drug development
December 18, 2018 - Artificial intelligence and the future of medicine
December 18, 2018 - Montana State doctoral student receives grant for her work to improve neuroscience tool
December 18, 2018 - Early postpartum initiation of opioids associated with persistent use
December 18, 2018 - Russian scientists identify molecular ‘switch’ that could be target for treatment of allergic asthma
December 18, 2018 - Surgeons make more mistakes in the operating room during stressful moments, shows study
December 18, 2018 - Immune cells explode themselves to inform about the danger of invading bacteria
December 18, 2018 - Malnutrition in children with Crohn’s disease linked with increased risk of surgical complications
December 18, 2018 - FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)
December 18, 2018 - The long and short of CDK12
December 18, 2018 - Hologic’s Cynosure division introduces TempSure Surgical RF technology in North America
December 18, 2018 - CMR Surgical partners with Nicholson Center to launch U.S.-based training program for Versius
December 18, 2018 - Findings reinforce guidelines for cautious use of antipsychotics in younger populations
December 18, 2018 - Study finds new strains of hepatitis C virus in sub-Saharan Africa
December 18, 2018 - New battery-free, implantable device aids weight loss
December 18, 2018 - Parental alcohol use disorder associated with offspring marital outcomes
December 18, 2018 - Novel Breast Imaging Technique Might Cut Unnecessary Biopsies
December 18, 2018 - What can a snowflake teach us about how cancer spreads in the body?
December 18, 2018 - Management of nausea and vomiting in pregnancy costs the NHS more than previously thought
December 18, 2018 - Green leafy vegetables may reduce risk of developing liver steatosis
December 18, 2018 - Veganism linked to nutrient deficiencies and malnutrition if not planned correctly
December 18, 2018 - Coming Soon: A Tiny Robot You Swallow to Help You Stay Healthy
December 18, 2018 - Modified malaria drug proven effective at inhibiting Ebola
December 18, 2018 - Study finds epigenetic differences in the brains of individuals with schizophrenia
December 18, 2018 - Fitness instructors’ motivational comments influence women’s body satisfaction
December 18, 2018 - Study focuses on modification of lipid nanoparticles for successful brain cell targeting
December 18, 2018 - New gut bacteria may be effective against obesity, metabolic and mental disorders
December 18, 2018 - New two-in-one powder aerosol to upgrade fight against deadly superbugs in lungs
December 18, 2018 - Biofilms feed with swirling flows
December 17, 2018 - Study identifies specific neurological changes related to traumatic brain injury
December 17, 2018 - New study confirms geographic bias in lung allocation for transplant
December 17, 2018 - Research focuses on optimization of solid lipid nanoparticle that encapsulates Vinorelbine bitartrate
December 17, 2018 - Carpal tunnel syndrome – Genetics Home Reference
December 17, 2018 - A novel insulin accelerant
December 17, 2018 - Tips for caring for patients with disabilities, from a mother and physician
December 17, 2018 - Menopause-related sexual, urinary problems tied to worse quality of life
Pharmacogenetic tests don’t provide much information for prescribing antidepressants or antipsychotics

Pharmacogenetic tests don’t provide much information for prescribing antidepressants or antipsychotics

image_pdfDownload PDFimage_print

Pharmacogenetic tests are marketed as an aid to psychiatrists in selecting the antidepressant or antipsychotic medication that will work best in individual patients, based on their genetic makeup. But for most patients, these pharmacogenetic tests don’t provide much useful information, beyond a basic understanding of how antidepressant and antipsychotic drugs are metabolized, suggests a study in the Journal of Psychiatric Practice. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Knowing the drug metabolism generally leads to the same conclusion as gene tests, according to the new research by Matthew Macaluso, DO, and Sheldon Preskorn, MD, of University of Kansas Medical Center, Wichita.

Knowing How Drugs Are Metabolized Predicts Which Will Be in the ‘Green Bin’

The researchers analyzed their experience with 19 patients with major depressive disorder who had not had a good response to previous antidepressant treatment. All patients underwent one type of pharmacogenetic test. These tests are marketed as “decision support tools” to aid in choosing and selecting the dose of antidepressant and antipsychotic drugs, based on genetic factors affecting blood levels of specific medications.

The test used in the study sorts drugs into red, yellow, and green “bins,” based on genes for certain enzymes involved in drug metabolism (cytochrome P450, or CYP enzymes) and how drugs are metabolized. Drs. Macaluso and Preskorn hypothesized that knowing the metabolic pathways for antidepressant and antipsychotic drugs would allow them to accurately predict which drugs would be sorted into the red, yellow, and green bins.

Two of the 22 antidepressants tested were sorted into the “green bin” for more than 90 percent of patients. Another eight antidepressants were “almost never” in the green bin – about ten percent of the time or less. Of the 16 antipsychotic drugs tested, four were “virtually always” and two were “almost never” in the green bin.

Medications that were more dependent on CYP enzymes for their metabolism generally appeared in the yellow and red bins. Drugs that were metabolized by the liver and those with a “narrow therapeutic index” requiring monitoring of blood drug levels were more likely to fall into the red bin versus the yellow bin.

Drugs that were almost always in the green bin tended to be newer medications that were not dependent on oxidative metabolism for their clearance. “Given these results, one could predict which drugs are found in the ‘green bin’ more than 90 percent of the time of the time simply on the basis of knowledge of their oxidative drug metabolism without knowing the results of the patient’s genetic testing,” the researchers write.

Drs. Macaluso and Preskorn suggest an alternative approach to antidepressant and antipsychotic prescribing, using information on metabolic pathways to choose a drug with a lower risk of variation in blood levels. The authors believe this method “may be more cost effective than genetic testing and may perhaps also be more practical.” The cost of pharmacogenetic testing is approximately $300.

In a previous article in Journal of Psychiatric Practice, Dr. Preskorn reviewed issues related to the use of new laboratory tests for psychiatry. He comments, “The value of pharmacogenetic tests in psychiatry is a major topic amongst clinicians today because the sales forces marketing them are pervasive, potent, and – unlike pharmaceutical companies – not regulated.” His review raises questions about the types of evidence put forth to support the value of testing, and notes the lack of regulation over the pharmacogenetic testing industry.

“Although pharmacogenetic testing will almost undoubtedly prove critical in customizing treatment in psychiatry, the critical question is whether that time is now,” Drs. Macaluso and Preskorn write. Based on their new findings, they add: “Pharmacogenetic testing in terms of guiding the selection of specific antidepressant and antipsychotic medications may not yet have reached the threshold of clinical utility.”​

Source:

http://home.lww.com/news.entry.html/2018/11/20/gene_testing_doesnt-T7U3.html

Tagged with:

About author

Related Articles